期刊文献+

LC-MS/MS法同时测定人血浆中瑞格列奈和二甲双胍及其在人体生物等效性研究中的应用(英文) 被引量:3

Liquid chromatography-tandem mass spectrometry simultaneous determination of repaglinide and metformin in human plasma and its application to bioequivalence study
原文传递
导出
摘要 建立灵敏、简便的液相色谱串联质谱法同时测定人血浆中的瑞格列奈和二甲双胍。采用d5-瑞格列奈和d6-二甲双胍作为内标,血浆样品经乙腈沉淀蛋白,以乙腈10 mmol.L1醋酸铵为流动相,通过Venusil ASBC18柱(150 mm×4.6 mm,5μm)梯度洗脱,色谱运行时间为7.5 min。采用大气压化学电离源,以多反应监测方式进行正离子检测。瑞格列奈标准曲线的线性范围为0.2~60.0 ng.mL1,二甲双胍为4~1 000 ng.mL1。两待测物的日内、日间精密度和准确度均小于15%。本方法灵敏、简便,已成功应用于人体药动学和生物等效性研究。 A simple, sensitive, selective, and reproducible liquid chromatography-tandem mass spectrometric method was developed for the simultaneous determination of repaglinide and metformin in human plasma using ds-repaglinide and d6-metformin as internal standards (ISs). After a simple protein precipitation using acetonitrile as the precipitation solvent, both analytes and ISs were separated on a Venusil ASB C 18 (150 mm x 4.6 mm, 5 p.m) via gradient elution using acetonitrile- 10 mmol.L-1 ammonium acetate as the mobile phase. A chromatographic total run time of 7.5 min was achieved. Mass spectrometric detection was conducted with atmospheric pressure chemical ionization under positive-ion and multiple-reaction monitoring modes. The method was linear over the 0.2 to 60.0 ng'mL-1 concentration range for repaglinide and over the 4 to 1 000 ng .mL-l range for metformin. For both analytes, the intra- and inter-accuracies and precisions were within the a:15% acceptable limit across all concentrations. The validated method was successfully applied to a clinical bioequivalence study.
出处 《药学学报》 CAS CSCD 北大核心 2013年第4期547-553,共7页 Acta Pharmaceutica Sinica
关键词 瑞格列奈 二甲双胍 LC—MS MS repaglinide: metformin: LC-MS/MS
  • 相关文献

参考文献2

二级参考文献14

  • 1曲斌,杭太俊,江丽.HPLC法测定人血浆中盐酸二甲双胍的浓度及其在药动学研究中的应用[J].中国新药杂志,2004,13(7):637-640. 被引量:17
  • 2刘世坤,裴奇,阳国平,张杰,李佐军,周于禄.格列吡嗪血药浓度测定及中国健康人体药物动力学研究[J].中南药学,2005,3(3):153-155. 被引量:3
  • 3尹然,陈晓辉,毕开顺.HPLC-MS研究格列吡嗪片人体药动学和生物等效性[J].中国药学杂志,2006,41(18):1405-1407. 被引量:5
  • 4Chen XY,Gu Q,Qiu F,et al.Rapid determination of metformin in human plasma by liquid chromatographytandem mass spectrometry method[J].J Chromatogr B,2004,802:377-381.
  • 5Heining K,Bucheli F.Fast liquid chromatographictandem mass spectrometric (LC-MS/MS) determination of metformin in plasma sample[J].J Pharm Biomed Anal,2004,34:1005-1011.
  • 6Marques MA,Soares AD,Pinto OW,et al.Simple and rapid method determination for metformin in human plasma using high performance liquid chromatography tandem mass spectrometry: application to pharmacokinetic studies[J].J Chromatogr B,2007,852:308-316.
  • 7Zarghi A,Foroutan SM,Shafaati A,et al.Rapid determination of metformin in human plasma using ionpair HPLC[J].J Pharm Biomed Anal,2003,31:197-200.
  • 8Huupponen R,Ojala-Karlsson P,Rouru J,et al.Determination of metformin in plasma by highperformance liquid chromatography[J].J Chromatogr,1992,583:270-273.
  • 9Lin ZJ,Desai-Krieger D,Shun L.Simultaneous determination of glipizide and rosiglitazone unbound drug concentration in plasma by equilibrium dialysis and liquid chromatography-tandem mass spectrometry[J].J Chromatogr B,2004,801:265-272.
  • 10ShenJP ZhuYQ ZhengMQ etal.The relative bioavailability of glipzide tablets in 20 healthy volunteers.中国临床药学杂志,2000,16:298-300.

共引文献16

同被引文献27

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部